Biofrontera (BFRIW) Shares Outstanding (Diluted Average) (2021 - 2025)
Biofrontera has reported Shares Outstanding (Diluted Average) over the past 5 years, most recently at $10.2 million for Q4 2025.
- Quarterly results put Shares Outstanding (Diluted Average) at $10.2 million for Q4 2025, up 84.4% from a year ago — trailing twelve months through Dec 2025 was $10.2 million (up 84.4% YoY), and the annual figure for FY2025 was $10.2 million, up 84.4%.
- Shares Outstanding (Diluted Average) for Q4 2025 was $10.2 million at Biofrontera, down from $10.8 million in the prior quarter.
- Over the last five years, Shares Outstanding (Diluted Average) for BFRIW hit a ceiling of $17.1 million in Q1 2022 and a floor of $902209.0 in Q2 2022.
- Median Shares Outstanding (Diluted Average) over the past 5 years was $5.1 million (2024), compared with a mean of $5.7 million.
- Biggest five-year swings in Shares Outstanding (Diluted Average): plummeted 92.21% in 2023 and later soared 274.39% in 2024.
- Biofrontera's Shares Outstanding (Diluted Average) stood at $8.0 million in 2021, then plummeted by 86.79% to $1.1 million in 2022, then skyrocketed by 46.29% to $1.5 million in 2023, then surged by 256.74% to $5.5 million in 2024, then surged by 84.4% to $10.2 million in 2025.
- The last three reported values for Shares Outstanding (Diluted Average) were $10.2 million (Q4 2025), $10.8 million (Q3 2025), and $9.4 million (Q2 2025) per Business Quant data.